The rising prevalence of co-morbidities such as diabetes and cardiovascular diseases among aging populations impacts the Dry Age-Related Macular Degeneration Market. These conditions often exacerbate AMD progression or complicate its management. Healthcare providers are thus focusing on integrated care models that address multiple chronic conditions simultaneously to optimize patient health outcomes.
Integrated care pathways include coordinated screening, monitoring, and treatment protocols that consider the interplay of various diseases. This holistic approach improves patient adherence to treatment plans and reduces the risk of complications. As healthcare systems globally adopt integrated care frameworks, the Dry Age-Related Macular Degeneration Market is expected to see enhanced demand for comprehensive diagnostic and therapeutic solutions.